{"id":"osrhsa","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL6068619","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"OsrHSA leverages human serum albumin (HSA) as a carrier platform to enhance drug stability, reduce immunogenicity, and prolong circulating half-life. This approach allows for less frequent dosing and potentially improved therapeutic efficacy by maintaining sustained drug exposure.","oneSentence":"OsrHSA is a recombinant human serum albumin fusion protein designed to extend the half-life and improve the pharmacokinetics of a therapeutic payload.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:24:52.295Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT06355479","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of OsrHSA in Patients of Hepatic Cirrhosis With Hypoalbuminemia","status":"COMPLETED","sponsor":"Healthgen Biotechnology Corp.","startDate":"2023-04-10","conditions":"Hypoalbuminemia, Hepatic Cirrhosis","enrollment":328},{"nctId":"NCT04835480","phase":"PHASE2","title":"A Phase II Study of OsrHSA in Patients With Decompensated Cirrhotic Ascites","status":"RECRUITING","sponsor":"Healthgen Biotechnology Corp.","startDate":"2021-03-22","conditions":"Cirrhotic Ascites","enrollment":220},{"nctId":"NCT04384523","phase":"PHASE1","title":"A Study of OsrHSA in Adult Healthy Male and Female Volunteers","status":"COMPLETED","sponsor":"Healthgen Biotechnology Corp.","startDate":"2019-11-04","conditions":"Ascites Hepatic","enrollment":41}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":13,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"OsrHSA","genericName":"OsrHSA","companyName":"Healthgen Biotechnology Corp.","companyId":"healthgen-biotechnology-corp","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}